Call to make cell & gene therapies affordable
cell and gene therapies
are good, but work towards making them affordable," Prof AK Sood, principal scientific advisor (PSA) to the Union govt told researchers Thursday.
But what are these therapies that Sood spoke about? They are cutting-edge medical treatments that aim to cure diseases at the source rather than just manage symptoms.
Gene therapy
fixes faulty genes. And
cell therapy
uses specially prepared cells - often taken from the patient or a donor - to help the body heal, or fight disease.
These are already being used to treat serious conditions like blood cancers and rare genetic diseases. But each treatment can cost lakhs or even crores, making them out of reach for most people. "If we want to make them widely accessible in India, we need a much larger and coordinated effort," Sood told researchers and innovators at India AMR Innovation Workshop held at C-CAMP here.
He said the Centre is working on a "Cell and Gene Therapy Mission" that will bring together several ministries and departments. Citing ImmunoACT - a CAR-T cell therapy for cancer treatment that uses the patient's own immune cells to fight the disease - developed with govt support as a good example, he said private companies are now stepping in to take it forward.
Pointing out that India lacks strong laws to stop over-the-counter sale of antibiotics, which is a major cause of
antimicrobial resistance (AMR)
, Sood blamed fake doctors, easy access to antibiotics, and high consultation fees for irresponsible usage.
Karnataka IT-BT secretary Ekroop Caur spoke about the rising danger of AMR, saying even people who don't misuse antibiotics can be affected because of what's happening in animals and plants. "That's why Karnataka launched a new AMR action plan this year."
C-CAMP CEO and director Taslimarif Saiyed warned AMR could lead to 10 million deaths a year if urgent action isn't taken.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
15 minutes ago
- New Indian Express
Piyush Goyal slams Siddaramaiah over Covid vaccine remarks, demand public apology
BENGALURU: Union Minister of Commerce and Industry Piyush Goyal hit out at Chief Minister Siddaramaiah for suggesting that the Covid-19 vaccine may have been linked to heart attack deaths, calling the remarks an insult to Indian scientists, startups, and the country's pharmaceutical strength. He demanded a public apology, stating that Siddaramaiah's comments undermined the people who worked tirelessly during the pandemic. Speaking at IIT Madras Sangam 2025 event on Saturday, Goyal said it was unfortunate that such a statement had come from the CM of a state, in a country known as the 'pharmacy of the world.' He said: 'Our scientists and startups worked day and night, conducted experiments, and built two vaccines when developed nations were struggling. India didn't just protect its own people but also supplied vaccines to 150 countries, giving them free to over 100 countries.' Goyal added: 'Now, when the world is thanking India for saving lives, Siddaramaiah is insulting those efforts. Is he siding with countries that have an agenda against the Indian government? What is he trying to say? He owes a public apology.' Referring to the early days of the Covid-19 pandemic, Goyal pointed out how India faced a severe shortage of PPE kits and vaccines. 'In just days, Indian startups and enterprises developed PPE kits locally and we became the second-largest producers in the world,' he said. 'When we tried to buy vaccines from abroad, we were pushed to the back of the line. Developed countries hoarded expensive vaccines. But India developed its own. Even today, people across the world thank India for saving lives,' he said, adding, 'And yet, the Chief Minister finds this a matter of shame?'
Hindustan Times
5 hours ago
- Hindustan Times
Govt officials among 35 booked in pan-India medical colleges scam
MUMBAI: The Central Bureau of Investigation (CBI) has exposed a network of officials from the Union health ministry, National Medical Commission (NMC), intermediaries, and representatives of private medical colleges, who manipulated the regulatory framework governing medical colleges across India. Govt officials among 35 booked in pan-India medical colleges scam The agency has booked 35 individuals for facilitating unauthorised access to highly confidential information on the regulatory status and internal processing of medical colleges, and the unlawful duplication and dissemination of such information. The accused have been charged with criminal conspiracy, bribery and corruption. They are also accused of disclosing inspection schedules and the identities of the inspection team to the medical colleges well in advance of the official communication, according to the CBI's First Information Report (FIR). The leaked information allegedly enabled medical colleges to bribe assessors, set up 'ghost faculty', falsify patient records, and tamper with biometric attendance systems to secure favourable inspection reports, CBI officials said. The accused included three members of the NMC inspection team, eight officials of the Union health ministry and a joint director-division head of the National Health Authority. Also among the accused are Mumbai-based Tata Institute of Social Sciences (TISS)'s chancellor DP Singh, who was chairperson of the University Grants Commission (UGC) from 2018 to 2021 (Despite repeated phone calls and text messages to Singh on Friday, HT was unable to reach him for comment). 'These acts, committed in exchange for monetary and other illicit considerations, undermine the integrity of the regulatory framework and jeopardise the quality of medical education and public health standards in the country,' the CBI FIR stated. The FIR was registered in New Delhi on June 30, under the Bharatiya Nyaya Sanhita (BNS) and the Prevention of Corruption Act. Charges include criminal conspiracy, demand and acceptance of undue advantage by public servants, public servants being bribed, bribing of a public servant by a commercial organisation and abetment of offences. The agency said its sources had revealed that a group of individuals, all of them officials associated with the ministry of health, were involved in unauthorised dissemination of sensitive, classified information relating to the inspection, renewal and issuance of letters of approval for medical colleges, in exchange for bribes. These individuals were alleged to have misused their official positions to track files within the ministry and take photographs of internal notations and comments made by senior ministry officials, according to the CBI FIR. These images were then allegedly shared via mobile phone with private individuals and representatives of medical colleges, thereby violating official secrecy protocols and compromising the integrity of the regulatory process, according to the FIR. Some of the accused allegedly extorted substantial sums of money from various private medical colleges in exchange for regulatory favours. The bribe money was allegedly routed to an accused in Delhi through hawala channels. The FIR alleges that one of the accused funded the construction of a temple he was building in Rajasthan, with the bribe money. It states that he gave ₹75 lakh for the temple's construction to a contractor from money received from an intermediary via hawala channels.
Time of India
6 hours ago
- Time of India
RDI scheme: Government aims to 'jumpstart India's R&D ecosystem'; offer low-interest funding for startups
This is an AI-generated image, used for representational purposes only. India's newly approved Research Development and Innovation (RDI) scheme, with a massive Rs 1 lakh crore corpus, is set to provide a major boost to private sector R&D and deep-tech startups by making long-term, affordable financing accessible for high-impact innovation projects, a senior government official said. The scheme, approved by the Union cabinet on July 1, is designed to ease funding constraints and foster a robust domestic innovation ecosystem. A senior government official cited by news agency PTI said that the RDI scheme is structured to help companies access long-term, low or nil-interest financing for high-risk, high-tech research projects. The initiative will also support equity-based funding for startups and facilitate the creation of a deep-tech Fund of Funds. The corpus will be managed through a Special Purpose Fund under the Anusandhan National Research Foundation (ANRF), with Rs 20,000 crore already allocated in the Union Budget for FY26. The government will provide a 50-year interest-free loan to the fund, which will further allocate capital to second-level fund managers, including AIFs, NBFCs, and Focused Research Organisations. The official further said that the aim is to help India "jumpstart its R&D ecosystem" by creating a mechanism where ministries can propose relevant technologies for inclusion under the scheme. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Secure Your Child's Future with Strong English Fluency Planet Spark Learn More Undo 'Any ministry that wants a technology included under the scheme can send a proposal to the department of science and technology,' the official added. The department of science and technology will act as the nodal agency for implementation and will issue detailed operational guidelines. These will include provisions to ensure effective capital recycling so that private sector RDI efforts continue to receive support over time. India currently spends just 0.65% of its GDP on R&D, significantly below the global average of 2.7%, and far lower than countries like Israel (6.3%) and South Korea (5%). According to officials, one of the key objectives is to change the perception in the private sector that R&D is a cost rather than an investment. Union minister Ashwini Vaishnaw said the scheme will also fund transformative, higher technology readiness projects, and assist in acquiring critical or strategically significant technologies. 'By addressing the critical need of the private sector for long-term, affordable financing, the RDI Scheme fosters self-reliance and global competitiveness,' he stated. The scheme will be overseen by multiple layers of governance. The governing board of ANRF, chaired by the Prime Minister, will provide strategic direction. An Executive Council under ANRF will approve project scopes and second-level fund managers. Meanwhile, an empowered group of secretaries headed by the cabinet secretary will periodically review the scheme's performance and recommend changes. Officials stressed that selected fund managers will include experts from industry, academia, finance, and technology sectors, ensuring that project evaluations remain independent and effective. Launched under the broader umbrella of Startup India , the RDI scheme adds another critical layer to India's ambition to become a global innovation powerhouse by 2047. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
